Please enable JavaScript.
Coggle requires JavaScript to display documents.
COVID19 Treatment in Development (Companies) (Immunotherapy (Anti…
COVID19 Treatment in Development (Companies)
Vaccines
mRNA based
Moderna
BioNTech, Pfizer, and Fosun Pharma
CureVac
Protein based
Ii-Key peptide vaccine
GlaxoSmithKline and Clover Biopharmaceuticals
iBio and Beijing CC-Pharming
Janssen Pharmaceutical Cos. (Johnson & Johnson) + Beth Israel Deaconess Medical Center (BIDMC)
Novavax + Emergent Biosolutions
Tonix Pharmaceuticals Holding
Altimmune
Vaxart and Emergent BioSolutions
CSL and The University of Queensland (UQ)
Medicago
Adenovirus Type 5 Vector
CanSino Biologics
DNA-based
Inovio Pharmaceuticals and Beijing Advaccine Biotechnology
LineaRx (Applied DNA Sciences) and Takis Biotech
Sanofi
Immunotherapy
Anti-inflammatory
Mallinckrodt
Mesoblast
Q Biomed and Mannin Research
RedHill Biopharma
Regeneron Pharmaceuticals and Sanofi
Roche (Genentech)
Tiziana Life Sciences and Novimmune
AIM ImmunoTech
Beijing Staidson Biopharma and InflaRx
Chugai Pharmaceutical and Zhejiang Hisun Pharmaceutical
CytoDyn
Anti-necrosis
Incyte, Shanghai Hengrui Pharmaceutical
BioXyTran
rhACE2
APEIRON Biologics
Defensin mimetic
Innovation Pharmaceuticals
T-cell therapy
BeyondSpring
CEL-SCI
NK Cell therapy
Celularity and Sorrento Therapeutics
Antiviral
RNA-dep RNA rep
Fujifilm Holdings and Zhejiang Hisun Pharmaceutical
Gilead Sciences
Pfizer
Biocryst
Protease inhibitors
Janssen Pharmaceutical Cos. (Johnson & Johnson)
AbbVie
Ascletis Pharma
Cocrystal and Kansas State University Research Foundation
Inhibit infiltration
NanoVirocides
Pharmstandard
Impact BioMedical
Antibodies
nAb
ImmunoPrecise Antibodies
Regeneron Pharmaceuticals
Distributed Bio
Hyperimmune
Emergent BioSolutions
Eli Lilly and AbCellera
Johns Hopkins
Kamada
Medicago
Vir Biotechnology and Biogen
Vir Biotechnology and NIAID
Vir Biotechnology and WuXi Biologics
Anti-virus nanobody
Beroni Group
Misc/Broad Spectrum
OyaGen
Bayer and numerous Chinese manufacturers